pirenzepine has been researched along with Vomiting in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine, which has been used anecdotally for chronic nausea in advanced cancer patients, might be a useful treatment for the prevention of delayed emesis in chemotherapy patients." | 5.32 | A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. ( Beaver, M; Brown, J; Comparet, J; Dickerson, P; Gray, D; Kirsh, KL; Passik, SD; Theobald, DE; Trowbridge, R, 2003) |
| "Nausea and vomiting are difficult symptoms to manage in patients with advanced cancer." | 5.32 | Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. ( Brito-Dellan, N; Davis, MP; Lagman, R; Leach, M; Srivastava, M, 2003) |
| "Olanzapine, which has been used anecdotally for chronic nausea in advanced cancer patients, might be a useful treatment for the prevention of delayed emesis in chemotherapy patients." | 1.32 | A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. ( Beaver, M; Brown, J; Comparet, J; Dickerson, P; Gray, D; Kirsh, KL; Passik, SD; Theobald, DE; Trowbridge, R, 2003) |
| "Nausea and vomiting are difficult symptoms to manage in patients with advanced cancer." | 1.32 | Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. ( Brito-Dellan, N; Davis, MP; Lagman, R; Leach, M; Srivastava, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passik, SD | 1 |
| Kirsh, KL | 1 |
| Theobald, DE | 1 |
| Dickerson, P | 1 |
| Trowbridge, R | 1 |
| Gray, D | 1 |
| Beaver, M | 1 |
| Comparet, J | 1 |
| Brown, J | 1 |
| Srivastava, M | 1 |
| Brito-Dellan, N | 1 |
| Davis, MP | 1 |
| Leach, M | 1 |
| Lagman, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Olanzapine as First Line Treatment for Prevention of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer: a Multicenter, Double-blind and Randomized Trial[NCT03571126] | Phase 4 | 156 participants (Anticipated) | Interventional | 2019-05-09 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pirenzepine and Vomiting
| Article | Year |
|---|---|
A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Benzodiazepines; Female; Humans; | 2003 |
Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Topics: Adult; Aged; Antiemetics; Benzodiazepines; Breast Neoplasms; Female; Humans; Lung Neoplasms; Nausea; | 2003 |